168 related articles for article (PubMed ID: 4406109)
1. Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol.
Niemegeers CJ; Janssen PA
Arzneimittelforschung; 1974 Jan; 24(1):45-52. PubMed ID: 4406109
[No Abstract] [Full Text] [Related]
2. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
Janssen PA; Niemegeers CJ; Schellekens KH; Dresse A; Lenaerts FM; Pinchard A; Schaper WK; van Nueten JM; Verbruggen FJ
Arzneimittelforschung; 1968 Mar; 18(3):261-79. PubMed ID: 4386815
[No Abstract] [Full Text] [Related]
3. Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Wauquier A
Arzneimittelforschung; 1975 Aug; 25(8):1287-94. PubMed ID: 1242360
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S
Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833
[No Abstract] [Full Text] [Related]
5. Azaperone, a sedative neuroleptic of the butyrophenone series with pronounced anti-aggressive and anti-shock activity in animals.
Niemegeers CJ; Van Nueten JM; Janssen PA
Arzneimittelforschung; 1974 Nov; 24(11):1798-1806. PubMed ID: 4480053
[No Abstract] [Full Text] [Related]
6. Synthesis and preliminary pharmacology of a novel butyrophenone derivative, ID-4708.
Honma T; Sasajima K; Ono K; Kitagawa S; Inaba S; Yamamoto H
Arzneimittelforschung; 1974 Sep; 24(9):1248-56. PubMed ID: 4479786
[No Abstract] [Full Text] [Related]
7. Behavioral pharmacologic studies in the monkey with DD-3480.
Shibuya T; Nishimori T; Matsuda H; Chen PC
Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):251-4. PubMed ID: 6125481
[TBL] [Abstract][Full Text] [Related]
8. The neuroleptics. 3. Pharmacology. Introduction.
Van Rossum JM; Janssen PA; Boissier JR; Julou L; Loew DM; Moller Nielsen I; Munkvad I; Randrup A; Stille G; Tedeschi DH
Mod Probl Pharmacopsychiatry; 1970; 5():23-32. PubMed ID: 5527165
[No Abstract] [Full Text] [Related]
9. Chemical and pharmacological classification of neuroleptics.
Janssen PA
Mod Probl Pharmacopsychiatry; 1970; 5():33-44. PubMed ID: 5535847
[No Abstract] [Full Text] [Related]
10. Pharmacology and biochemistry of haloperidol.
Niemegeers CJ; Laduron PM
Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):3-8. PubMed ID: 14331
[No Abstract] [Full Text] [Related]
11. Bromperidol, a new potent neuroleptic of the butyrophenone series. A comparison of the effects of bromperidol and haloperidol in intracranial self-stimulation.
Wauquier A; Niemegeers CJ
Arzneimittelforschung; 1976; 26(7):1356-9. PubMed ID: 1036924
[TBL] [Abstract][Full Text] [Related]
12. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
Khisti RT; Deshpande LS; Chopde CT
Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
[TBL] [Abstract][Full Text] [Related]
13. [The characteristics of the development of cataleptic phenomena during the action of a new Ukrainian neuroleptic--a butyrophenone derivative--in experiments on mice].
Shapovalova VO; Mykhaĭlov VS; Shapovalov VV
Fiziol Zh (1994); 1999; 45(3):114-7. PubMed ID: 10439301
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological studies of an antipschotic agent, penfluridol. (1). The central pharmacological actions].
Ito K; Nurimoto S; Shintomi K; Kowa Y; Yamamura M; Ishida R
Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):795-813. PubMed ID: 828132
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology and biochemistry of bromperidol.
Niemegeers CJ; Laduron PM; Janssen PA
Acta Psychiatr Belg; 1978; 78(1):37-50. PubMed ID: 645406
[No Abstract] [Full Text] [Related]
16. Pharmacology of cis(Z)-clopenthixol decanoate, a depot neuroleptic.
Pedersen V; Svendsen O; Danneskiold-Samsoe P; Boeck V; Nielsen IM
Acta Pharmacol Toxicol (Copenh); 1977 Apr; 40(4):482-90. PubMed ID: 577108
[TBL] [Abstract][Full Text] [Related]
17. The influence of various neuroleptic drugs on shock avoidance responding in rats. II. Nondiscriminated Sidman avoidance procedure with alternate reinforcement and extinction periods and analysis of the interresponse times (IRT's).
Niemegeers CJ; Verbruggen FJ; Janssen PA
Psychopharmacologia; 1969; 16(3):175-82. PubMed ID: 5391696
[No Abstract] [Full Text] [Related]
18. The influence of various neuroleptic drugs on shock avoidance responding in rats. 3. Amphetamine antagonism in the discriminated Sidman avoidance procedure.
Niemegeers CJ; Verbruggen FJ; Janssen PA
Psychopharmacologia; 1970; 17(2):151-9. PubMed ID: 5443882
[No Abstract] [Full Text] [Related]
19. The predictive value of the anti-apomorphine test in dogs for neuroleptic therapy in man.
Niemegeers CJ
Act Nerv Super (Praha); 1974 Mar; 16(1):56-8. PubMed ID: 4454942
[No Abstract] [Full Text] [Related]
20. Pharmacology of neuroleptics upon repeated administration.
Moller Nielsen I; Fjalland B; Pedersen V; Nymark M
Psychopharmacologia; 1974 Jan; 34(2):95-104. PubMed ID: 4856370
[No Abstract] [Full Text] [Related]
[Next] [New Search]
